Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aripiprazole for Pervasive Developmental Disorders
NCT00870727Phase 3Completed
- Sponsor
- Indiana University
- Start
- Feb 2009
- Primary completion
- Mar 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of aripiprazole in pervasive developmental disorder (PDD), sponsored by Indiana University. Started Feb 2009; status: completed.
02
Drugs
aripiprazole
03
Conditions
pervasive developmental disorder (PDD)
Beyond the preview
Go deeper on NCT00870727.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00870727.